Back

CytoDyn closes $16.5 million financing to advance leronlimab oncology programs

Verifying
  • CytoDyn closed a $16.5 million financing with Paulson Investment Company as placement agent.
  • The September 1, 2026 financing is expected to fund operations into the second half of 2027.
  • CytoDyn filed its Form 10-K on August 31, 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
CytoDyn closes $16.5 million financing to advance leronlimab oncology programs - CoinPost Terminal